Prollenium
Entry
2021
Hold
5yr
Status
Active
Who owns Prollenium?
Prollenium is a Canadian HealthTech company, currently owned by ARCHIMED since 2021 and Peugeot Invest.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Peugeot InvestDirect investment by Peugeot Invest · 2025 · Growth
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
ARCHIMEDActive
2021 · present(5yr) · MED III · 2021 · Buyout
Peugeot InvestActive
2021 · present(5yr) · Direct investment by Peugeot Invest · 2025 · Growth
More from Direct investment by Peugeot Invest
Other portfolio companies in the same fund.
France
Germany
US
LuxembourgMore PE-backed in HealthTech
Comparable healthtech deals from other GPs.
UK
Questions
Who owns Prollenium?
Prollenium is currently owned by ARCHIMED and Peugeot Invest, through Direct investment by Peugeot Invest, since 2021.
When did ARCHIMED and 1 other acquire Prollenium?
ARCHIMED and 1 other acquired Prollenium in 2021.
Who has owned Prollenium over time?
Prollenium has been through 2 private-equity ownership periods: ARCHIMED · via MED III · since 2021; Peugeot Invest · via Direct investment by Peugeot Invest · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue